Researchers isolated and characterized new and known compounds from Uncaria rhynchophylla. X-ray diffraction on single crystals provided structural information, improving quality monitoring of botanical raw materials. This helps uncover potential bioactive constituents for traditional medicine.
Summary: Traditional Chinese medicine Gouteng shows neuroprotective benefits in neurodegenerative diseases like Parkinson's and Alzheimer's. Compounds like corynoxine B offer potential for new drug development. Relevant for aging population health.
YGS treat tremor-dominant Parkinson's by multiple mechanisms. Components analyzed, selected, standardized. Includes Gouteng, Chaihu, Chuanxiong, Danggui, Fuling, Baizhu, Gancao. Important for Parkinson's research and treatment.
Alkaloids from Uncaria rhynchophylla show promise in treating Parkinson's disease by reducing inflammation and oxidative stress. Understanding their mechanism could lead to new therapies.
UR and URA from Uncaria rhynchophylla show neuroprotective effects for Alzheimer's and other CNS diseases. Mechanisms not fully understood.Important for potential medical treatments.
Scientists identified new alkaloids in , which showed promising anti-neuroinflammatory effects by inhibiting NO production in microglial cells. Compounds , , , , , , and were particularly effective, with IC values of 5.87-76.78 M.
Medical Uncariae Ramulus Cum Uncis (URCU) is a plant consisting of various Uncaria species widely used in traditional remedies. URCU extracts have shown neuroprotective, antioxidant, anti-inflammatory, anticancer, antibacterial, and autophagy-enhancer properties in pharmacological studies.
Researchers found that S-adenosylmethionine decarboxylase is the most stable reference gene in a medicinal herb, with potential to enhance alkaloid production through synthetic biology.
Gouteng shows potential for treating Alzheimer's by reversing tau hyperphosphorylation and offering neuroprotective effects, according to network pharmacology and molecular docking. Care should be taken as it may be a therapeutic option for AD.
Scientists isolated seven new monoterpene alkaloids and 16 known analogues from a plant. They determined their structures using spectroscopic analysis and X-ray diffraction. The compounds have unique structures and belong to a novel type of alkaloids.
Researchers developed a method using supercritical fluid extraction and chromatography to separate and identify indole alkaloids in Uncaria rhynchophylla. This method improves specificity and allows for the analysis of alkaloids in complex samples.
Researchers investigated the potential of Baichanting Compound (BCT), a Chinese herbal prescription, to treat Parkinson's disease (PD). BCT contains Acanthopanax senticosus, Paeonia lactiflora, and Uncaria rhynchophylla. This study may provide insights into a novel treatment option for PD.
Scientists found that Corynoxine B (Cory B), a natural alkaloid, enhances autophagy to promote clearance of abnormal protein aggregates in Parkinson's disease. Cory B binds to HMGB1/2, increases Beclin 1/VPS34 complex activity, and improves behavioral abnormalities in PD animal models, suggesting its neuroprotective potential.
This study investigates the potential of hirsuteine, an indole alkaloid found in a traditional Chinese herbal medicine called Uncaria rhynchophylla, as an anticancer agent for colorectal cancer (CRC). The researchers aim to understand how HST works against CRC and its underlying mechanism. This research is important as it may provide insight into new treatment options for CRC, a common and potentially deadly cancer.
Researchers studied the effects of Rhynchophylline (RIN), a compound with anti-inflammatory and neuroprotective properties, on a mouse model of Parkinson's disease (PD). They used a combination of tests and assays to determine that RIN improved behavior, reduced neuron loss, and regulated metabolic disorders in the mice. The study showed that RIN has potential as a therapeutic agent for PD by reducing inflammation, maintaining metabolic balance, and suppressing certain proteins in the brain.
Researchers investigated the effects of isorhynchophylline on stress-induced emotional disorders and cognitive impairment. They conducted experiments on mice, observing their cognitive abilities and emotional responses under stress. The study found that isorhynchophylline had positive effects on both emotional and cognitive functions, suggesting a potential therapeutic use for humans. Further studies should explore this possibility.
Researchers isolated ten new indole alkaloids from the Uncaria rhynchophylla plant, as well as eleven known analogs. These compounds were evaluated for their bioactivity on dopamine D2 and Mu opioid receptors. Two compounds showed significant antagonistic activity on both receptors, making them promising for developing natural therapeutic drugs for central nervous system diseases.
This study used a network pharmacology approach to investigate the potential of certain alkaloids found in Uncaria Rhynchophylla (UR) for treating Alzheimer's disease (AD). The researchers identified 10 alkaloids that corresponded to 90 anti-AD targets. They found that corynoxine, corynantheine, isorhynchophylline, dihydrocorynatheine, and isocorynoxeine are likely to become key components for AD treatment. KEGG pathway enrichment analysis revealed that the Alzheimer's disease pathway was the most significantly enriched in alkaloids against AD. The study also found that UR alkaloids directly exert an AD treatment effect by acting on multiple pathological processes in AD. These findings suggest that UR alkaloids could be further studied as potential treatments for AD.
Researchers conducted a study to determine if Uncaria rhynchophylla could be effective in treating depression. They induced depression in rats and then administered the herb to some while providing a placebo to others. The rats treated with the herb showed a decrease in depression-like symptoms and an increase in the neurotransmitter serotonin. The study suggests that the herb may be a useful treatment option for depression. However, further research is needed to determine its efficacy in humans.
This study looked at the potential benefits of the herb Uncaria rhynchophylla in treating conditions affecting the central nervous system. This herb is commonly used in Chinese medicine to treat convulsions, hypertension, epilepsy, and other cerebral diseases. Researchers focused on the active components of the herb, including alkaloids, terpenoids, and flavonoids. The study found that U. rhynchophylla had protective effects on the CNS, supporting its use in traditional medicine. These findings suggest that the herb may have potential as a natural remedy for certain neurological conditions. Overall, further research is needed to fully understand the benefits of U. rhynchophylla for human health.